JP2016028097A5 - - Google Patents

Download PDF

Info

Publication number
JP2016028097A5
JP2016028097A5 JP2015195560A JP2015195560A JP2016028097A5 JP 2016028097 A5 JP2016028097 A5 JP 2016028097A5 JP 2015195560 A JP2015195560 A JP 2015195560A JP 2015195560 A JP2015195560 A JP 2015195560A JP 2016028097 A5 JP2016028097 A5 JP 2016028097A5
Authority
JP
Japan
Prior art keywords
lutein
food
effect
pharmaceutical composition
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015195560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016028097A (ja
JP6049108B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015195560A priority Critical patent/JP6049108B2/ja
Priority claimed from JP2015195560A external-priority patent/JP6049108B2/ja
Publication of JP2016028097A publication Critical patent/JP2016028097A/ja
Publication of JP2016028097A5 publication Critical patent/JP2016028097A5/ja
Application granted granted Critical
Publication of JP6049108B2 publication Critical patent/JP6049108B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015195560A 2010-03-24 2015-10-01 覚醒時間延長剤 Expired - Fee Related JP6049108B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015195560A JP6049108B2 (ja) 2010-03-24 2015-10-01 覚醒時間延長剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010067524 2010-03-24
JP2010067524 2010-03-24
JP2015195560A JP6049108B2 (ja) 2010-03-24 2015-10-01 覚醒時間延長剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012506960A Division JPWO2011118468A1 (ja) 2010-03-24 2011-03-16 覚醒時間延長剤

Publications (3)

Publication Number Publication Date
JP2016028097A JP2016028097A (ja) 2016-02-25
JP2016028097A5 true JP2016028097A5 (enExample) 2016-04-07
JP6049108B2 JP6049108B2 (ja) 2016-12-21

Family

ID=44673025

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012506960A Withdrawn JPWO2011118468A1 (ja) 2010-03-24 2011-03-16 覚醒時間延長剤
JP2015195560A Expired - Fee Related JP6049108B2 (ja) 2010-03-24 2015-10-01 覚醒時間延長剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012506960A Withdrawn JPWO2011118468A1 (ja) 2010-03-24 2011-03-16 覚醒時間延長剤

Country Status (4)

Country Link
JP (2) JPWO2011118468A1 (enExample)
CN (1) CN102933210A (enExample)
IN (1) IN2012DN06612A (enExample)
WO (1) WO2011118468A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002223787A (ja) * 2001-02-01 2002-08-13 Yakult Honsha Co Ltd ルテインおよび高純度ルテインの取得方法
JP5191764B2 (ja) * 2007-03-30 2013-05-08 理研ビタミン株式会社 睡眠改善剤
JP2010538674A (ja) * 2007-09-19 2010-12-16 オフサルモファーマ・アクチェンゲゼルシャフト 栄養補助剤およびそのような補助剤を含む強化食品
JP2009159929A (ja) * 2007-12-13 2009-07-23 Fujifilm Corp 油性組成物
JP2009242309A (ja) * 2008-03-31 2009-10-22 Ezaki Glico Co Ltd 皮膚外用剤、口腔用組成物および飲食品
WO2010061574A1 (ja) * 2008-11-25 2010-06-03 財団法人大阪バイオサイエンス研究所 睡眠改善剤および鎮静剤ならびにそれらの使用

Similar Documents

Publication Publication Date Title
Nader-Macías et al. Profiles and technological requirements of urogenital probiotics
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
PH12018501298A1 (en) Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
WO2019098823A8 (en) Composition comprising a2 b-casein and a vegetable fat mixture
JP2015533509A5 (enExample)
MX2016006503A (es) Formulacion de bifidobacterium lactis ncc 2818 tratada con calor que reduce las manifestaciones alergicas.
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
IN2014MU00327A (enExample)
JP2016210758A5 (enExample)
JP2016028097A5 (enExample)
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
MX2017000384A (es) Forma de dosificacion en capsulas de succinato de metoprolol.
HK1216860A1 (zh) 单次高剂量的mva在新生儿和婴儿中诱导保护性免疫反应
MX2019015889A (es) Administracion de vitamina b6 materna para la prevencion del aumento de la adiposidad, el sobrepeso a la obesidad en la descendencia.
JP2018177734A5 (enExample)
Kohut et al. Inside Venezuela's Crumbling Mental Hospitals
WO2016075595A3 (en) Food products and processes for preparation thereof
WO2016027225A8 (en) A composition having a muscle-relaxant and anti-inflammatory activity
JP2019011314A5 (enExample)
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
CN102948661A (zh) 具有刺激大肠蠕动预防肠癌功效的保健品
Hsieh et al. Novel Concepts to Develop an" All-in-One" Functional Food for Health and Disease Prevention in the 21~(st) Century by Biomarkers Technology
WO2015126151A3 (ko) 신곡 추출물을 포함하는 상처 치료용 조성물